![Kyle Piskel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 4 M $ in data 31/05/2026
Kyle Piskel is currently the Chief Financial & Accounting Officer at Adaptive Biotechnologies Corp., a position held since 2024.
The career at Adaptive Biotechnologies Corp.
began in 2015 and is ongoing.
Education includes an undergraduate degree from Eastern Washington University and a graduate degree from Gonzaga University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 18/05/2026 | 256.725 ( 0,16% ) | 4 M $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ADAPTIVE BIOTECHNOLOGIES CORPORATION | Direttore Finanziario/CFO | 08/04/2024 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 3 |
|---|---|
Eastern Washington University
 Eastern Washington University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gonzaga University
 Gonzaga University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adaptive Biotechnologies Corp.
 Adaptive Biotechnologies Corp. BiotechnologyHealth Technology Develops minimal residual disease and immune medicine | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
